Zurcher Kantonalbank (Zurich Cantonalbank) Roivant Sciences Ltd. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $39 Billion
 - Q2 2025
 
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 114,340 shares of ROIV stock, worth $2.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
114,340
              Previous 102,478
              
        
           11.58%
        
      
          
        Holding current value
$2.24 Million
            Previous $1.03 Million
            
        
           24.56%
        
      
          
        % of portfolio
0.0%
            Previous 0.0%
          
        Shares
	  11 transactions
	
  Others Institutions Holding ROIV
# of Institutions
364Shares Held
456MCall Options Held
8.36MPut Options Held
760K- 
    
      Sb Investment Advisers (Uk) LTD London, X060MShares$1.18 Billion5.36% of portfolio
 - 
    
      Morgan Stanley New York, NY44.7MShares$876 Million0.03% of portfolio
 - 
    
      Vanguard Group Inc Valley Forge, PA39.3MShares$771 Million0.01% of portfolio
 - 
    
      Black Rock Inc. New York, NY35.4MShares$693 Million0.01% of portfolio
 - 
    
      Viking Global Investors LP34.2MShares$671 Million1.22% of portfolio
 
About Roivant Sciences Ltd.
- Ticker ROIV
 - Exchange NASDAQ
 - Sector Healthcare
 - Industry Biotechnology
 - Shares Outstandng 704,382,976
 - Market Cap $13.8B
 - Description
 - Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...